«上一篇/Previous Article|本期目录/Table of Contents|下一篇/Next Article»

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:

2016年第5期

页码:

597-600

栏目:

综述

出版日期:

2016-04-25

文章信息/Info

Title:

Development of molecular imaging and precision medicine in coronary atherosclerosis plaques

作者:

王 昭¹; 2; 曹 丰¹

（1.中国人民解放军总医院心内科，北京 100853；
2.南开大学医学院研究生院，天津 300071）

Author(s):

WANG Zhao¹; 2;  CAO Feng¹

(1.Department of Cardiology, PLA General Hospital, Beijing 100853, China；
2.Graduate School, School of Medicine, Nankai University, Tianjin 300071, China)

关键词:

动脉粥样硬化; 精准医学; 分子影像学; 纳米技术

Keywords:

atherosclerosis;  precision medicine;  molecular imaging;  nanotechonology

分类号:

R541.4；R445；R19

DOI:

-

文献标识码:

A

摘要:

动脉粥样硬化斑块破裂具有隐匿性和突发性的特点，可诱发包括心源性猝死等严重心血管事件，但是目前临床常用的检查手段难以对易损斑块进行早期人群筛查。分子影像为斑块的早期诊断带来了新的契机，同时精准医学概念可指导斑块的精准诊治。本综述主要阐述了在精准医学的理念下，结合心血管疾病病理生理、生物医学工程和纳米技术对动脉粥样硬化斑块进行精准诊治的分子影像学进展。

Abstract:

Atherosclerotic plaques may rupture without warning and cause acute cardiovascular events such as sudden cardiac death. Unfortunately, current diagnostic tools are insufficient to identify high-risk patients during the early stage of the disease. Molecular imaging brings new opportunity for early plaque diagnosis. Meanwhile, the concept of precision medicine may guide the accurate diagnosis and treatment of atherosclerosis plaques. This review describes the development of molecular imaging with the integration of cardiovascular physiopathology, biomedical engineering and nanotechnology under the concept of precision medicine.

参考文献/References

[1]Swirski FK,Nahrendorf M.Leukocyte behavior in atherosclerosis, myocardial infarction,and heart failure[J]. Science,2013,339(6116):161-166.
[2]Libby P.Inflammation in atherosclerosis[J].Nature,2002,420(6917):868-874.
[3]Mitka M.New basic care goals seek to rein in global rise in cardiovascular disease[J].JAMA,2012,308(17):1725-1726.
[4]Chen IY,Wu JC.Cardiovascular molecular imaging:focus on clinical translation[J].Circulation,2011,123(4):425-443.
[5]Owen DR,Lindsay AC,Choudhury RP,et al.Imaging of atherosclerosis[J].Annu Rev Med,2011,62(25-40).
[6]Tabas I,Glass CK.Anti-inflammatory therapy in chronic disease:challenges and opportunities[J].Science,2013,339(6116):166-172.
[7]Collins FS,Varmus H.A new initiative on precision medicine[J].N Engl J Med,2015,372(9):793-795.
[8]Manning HC.World molecular imaging congress 2015:precision medicine visualized[J].Mol Imaging Biol,2015,17(3):295-296.
[9]Tang D,Yang C,Zheng J,et al.Image-based modeling and precision medicine:patient-specific carotid and coronary plaque assessment and predictions[J].IEEE Trans Biomed Eng,2013,60(3):643-651.
[10]Moore KJ,Tabas I.Macrophages in the pathogenesis of atherosclerosis[J].Cell,2011,145(3):341-355.
[11]Lusis AJ.Atherosclerosis[J].Nature,2000,407(6801):233-241.
[12]Porche DJ.Precision medicine initiative[J].Am J Mens Health,2015,9(3):177.
[13]Montine TJ,Montine KS.Precision medicine:Clarity for the clinical and biological complexity of Alzheimer’s and Parkinson’sdiseases[J].J Exp Med,2015,212(5):601-605.
[14]Peterson TA,Doughty E,Kann MG.Towards precision medicine: advances in computational approaches for the analysis of human variants[J].J Mol Biol,2013,425(21):4047-4063.
[15]Wildgruber M,Swirski FK,Zernecke A.Molecular imaging of inflammation in atherosclerosis[J].Theranostics,2013,3(11):865-884.
[16]Mulder WJ,Jaffer FA,Fayad ZA,et al.Imaging and nanomedicine in inflammatory atherosclerosis[J].Sci Transl Med,2014,6(239):239sr231.
[17]Roessl E,Proksa R.K-edge imaging in x-ray computed tomography using multi-bin photon counting detectors[J].Phys Med Biol,2007,52(15):4679-4696.
[18]Cormode DP,Roessl E,Thran A,et al.Atherosclerotic plaque composition:analysis with multicolor CT and targeted gold nanoparticles[J].Radiology,2010,256(3):774-782.
[19]Fleg JL,Stone GW,Fayad ZA,et al.Detection of high-risk atherosclerotic plaque:report of the NHLBI Working Group on current status and future directions[J].JACC Cardiovasc Imaging,2012,5(9):941-955.
[20]Kwee RM,Truijman MT,van Oostenbrugge RJ,et al.Longitudinal MRI study on the natural history of carotid artery plaques in symptomatic patients[J].PLoS One,2012,7(7):e42472.
[21]Heidt T,Nahrendorf M.Multimodal iron oxide nanoparticles for hybrid biomedical imaging[J].NMR Biomed,2013,26(7):756-765.
[22]Tang TY,Muller KH,Graves MJ,et al.Iron oxide particles for atheroma imaging[J].Arterioscler Thromb Vasc Biol,2009,29(7):1001-1008.
[23]Tang T,Howarth SP,Miller SR,et al.Assessment of inflammatory burden contralateral to the symptomatic carotid stenosis using high-resolution ultrasmall,superparamagnetic iron oxide-enhanced MRI[J].Stroke,2006,37(9):2266-2270.
[24]Tang TY,Howarth SP,Miller SR,et al.The ATHEROMA (Atorvastatin Therapy:Effects on Reduction of Macrophage Activity)Study.Evaluation using ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging in carotid disease[J].J Am Coll Cardiol,2009,53(22):2039-2050.
[25]Skajaa T,Cormode DP,Falk E,et al.High-density lipoprotein-based contrast agents for multimodal imaging of atherosclerosis[J].Arterioscler Thromb Vasc Biol,2010,30(2):169-176.
[26]Dutta P,Courties G,Wei Y,et al.Myocardial infarction accelerates atherosclerosis[J].Nature,2012,487(7407):325-329.
[27]Kim EJ,Kim S,Kang DO,et al.Metabolic activity of the spleen and bone marrow in patients with acute myocardial infarction evaluated by 18f-fluorodeoxyglucose positron emission tomograpic imaging[J].Circ Cardiovasc Imaging,2014,7(3):454-460.
[28]Lobatto ME,Fayad ZA,Silvera S,et al.Multimodal clinical imaging to longitudinally assess a nanomedical anti-inflammatory treatment in experimental atherosclerosis[J].Mol Pharm,2010,7(6):2020-2029.
[29]Weissleder R,Nahrendorf M,Pittet MJ.Imaging macrophages with nanoparticles[J].Nat Mater,2014,13(2):125-138.
[30]Nahrendorf M,Zhang H,Hembrador S,et al.Nanoparticle PET-CT imaging of macrophages in inflammatory atherosclerosis[J].Circulation,2008,117(3):379-387.
[31]Majmudar MD,Yoo J,Keliher EJ,et al.Polymeric nanoparticle PET/MR imaging allows macrophage detection in atherosclerotic plaques[J].Circ Res,2013,112(5):755-761.
[32]Jaffer FA,Calfon MA,Rosenthal A,et al.Two-dimensional intravascular near-infrared fluorescence molecular imaging of inflammation in atherosclerosis and stent-induced vascular injury[J].J Am Coll Cardiol,2011,57(25):2516-2526.
[33]Tearney GJ,Yabushita H,Houser SL,et al.Quantification of macrophage content in atherosclerotic plaques by optical coherence tomography[J].Circulation,2003,107(1):113-119.
[34]Yoo H,Kim JW,Shishkov M,et al.Intra-arterial catheter for simultaneous microstructural and molecular imaging in vivo[J].Nat Med,2011,17(12):1680-1684.
[35]Winter PM,Morawski AM,Caruthers SD,et al.Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v)beta3-integrin-targeted nanoparticles[J].Circulation,2003,108(18):2270-2274.
[36]Winter PM,Neubauer AM,Caruthers SD,et al.Endothelial alpha(v)beta3 integrin-targeted fumagillin nanoparticles inhibit angiogenesis in atherosclerosis[J]. Arterioscler Thromb Vasc Biol,2006,26(9):2103-2109.
[37]Duivenvoorden R,Tang J,Cormode DP,et al.A statin-loaded reconstituted high-density lipoprotein nanoparticle inhibits atherosclerotic plaque inflammation[J].Nat Commun,2014,5:3065.
[38]Leuschner F,Dutta P,Gorbatov R,et al.Therapeutic siRNA silencing in inflammatory monocytes in mice[J].Nat Biotechnol,2011,29(11):1005-1010.
[39]Kamaly N,Fredman G,Subramanian M,et al.Development and in vivo efficacy of targeted polymeric inflammation-resolving nanoparticles[J].Proc Natl Acad Sci U S A,2013,110(16):6506-6511.

备注/Memo

备注/Memo:

收稿日期：2015-08-03.
通讯作者：曹丰，主任医师，主要从事心肌再生机制及干预及在体分子影像研究 Email：wind8828@gmail.com
作者简介：王昭，硕士生 Email：wzhaogz@126.com

常用功能

更新日期/Last Update: 2016-04-13